Global Postpartum Depression Drugs Market Size & Outlook
Global postpartum depression drugs market, 2018-2030 (US$M)
Related Markets
Global postpartum depression drugs market highlights
- The global postpartum depression drugs market generated a revenue of USD 838.4 million in 2023 and is expected to reach USD 1,589.9 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 9.6% by 2030.
- In terms of segment, postpartum anxiety accounted for a revenue of USD 185.8 million in 2023.
- Postpartum Anxiety is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 838.4 million |
| Market revenue in 2030 | USD 1,589.9 million |
| Growth rate | 9.6% (CAGR from 2024 to 2030) |
| Largest segment | Postpartum anxiety |
| Fastest growing segment | Postpartum Anxiety |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Postpartum Blues, Postpartum Anxiety, Postpartum Obsessive-Compulsive Disorder (OCD), Postpartum Post-Traumatic Stress Disorder (PTSD), Postpartum Panic Disorder, Postpartum Psychosis |
Other key industry trends
- In terms of revenue, the North America accounted for 38.5% of the global postpartum depression drugs market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, India is the fastest growing regional market and is projected to reach USD 56.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Postpartum Depression Drugs Market Scope
Postpartum Depression Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Sage Therapeutics Inc | View profile | 487 | 215 First Street, Cambridge, MA, United States, 02142 | https://www.sagerx.com |
| Bausch Health Companies Inc | View profile | 20270 | 2150 Saint Elzear Boulvard West, Laval, QC, Canada, H7L 4A8 | https://www.bauschhealth.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Cipla Ltd DR | View profile | 38955 | Ganpatrao Kadam Marg, Cipla House, Peninsula Business Park, Lower Parel, Mumbai, MH, India, 400 013 | https://www.cipla.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global postpartum depression drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to postpartum depression drugs market will help companies and investors design strategic landscapes.
Postpartum anxiety was the largest segment with a revenue share of 22.16% in 2023. Horizon Databook has segmented the Global postpartum depression drugs market based on postpartum blues, postpartum anxiety, postpartum obsessive-compulsive disorder (ocd), postpartum post-traumatic stress disorder (ptsd), postpartum panic disorder, postpartum psychosis covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Postpartum Depression Drugs Type Outlook (Revenue, USD Million, 2018-2030)
- Postpartum Post-Traumatic Stress Disorder (PTSD)
- Postpartum Psychosis
- Postpartum Obsessive-Compulsive Disorder (OCD)
- Postpartum Panic Disorder
- Postpartum Blues
- Postpartum Anxiety
- Global Postpartum Depression Drugs Treatment Type Outlook (Revenue, USD Million, 2018-2030)
- Hormonal Therapy
- Pharmacotherapy
- Others
- Global Postpartum Depression Drugs Route of Administration Outlook (Revenue, USD Million, 2018-2030)
- Others
- Oral
- Parenteral
- Global Postpartum Depression Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Others (online pharmacy)
- Hospital Pharmacy
- Retail Pharmacy
Reasons to subscribe to Global postpartum depression drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global postpartum depression drugs market databook
-
Our clientele includes a mix of postpartum depression drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global postpartum depression drugs market , including forecasts for subscribers. This global databook contains high-level insights into Global postpartum depression drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global postpartum depression drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Postpartum depression drugs market size, 2023 (US$M)
Global postpartum depression drugs market share, by treatment type, 2023 & 2030 (%, US$M)
Postpartum depression drugs market: Opportunity assessment by country
Global postpartum depression drugs market, by region, 2023 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
